News

ICICI Bank, HAL among 32 most preferred stocks in Nomura’s portfolio

Sectoral Snapshot Post Q4 Earnings
ETMarkets.com
1/7
Sectoral Snapshot Post Q4 Earnings
The Q4FY24 earnings season has now concluded, with overall results coming in better than expected across several sectors. Companies reported healthy earnings growth supported by strong margin profiles and resilient demand trends. Despite global macro uncertainties, many sectors outperformed initial estimates, providing some comfort on FY26 visibility.

Following the earnings season, global brokerage house Nomura has outlined its sector-wise preferences and stock recommendations. The brokerage has taken a constructive view on multiple segments, offering a detailed thesis and most-preferred stock picks for each sector.
Positive on select companies
Shutterstock.com
2/7
Positive on select companies
Financials: Axis Bank, ICICI Bank, SBI, Shriram Finance, Bajaj Finance, Max Financial, HDFC AMC
Consumer Staples/FMCG: Marico, Godrej Consumer Products, Tata Consumer Products
 Positive on diagnostics, pharmacy
ANI
3/7
Positive on diagnostics, pharmacy
Nomura is positive on diagnostics and pharmacy companies within the healthcare services. These include Medplus and Dr. Lal PathLabs
Cautious stance on metals; prefer steel over other metals
Agencies
4/7
Cautious stance on metals; prefer steel over other metals
Metals: Jindal Steel & Power
Positive Stance
ETMarkets.com
5/7
Positive Stance
Consumer Discretionary/Durables: Dixon Technologies
Autos: Mahindra & Mahindra, Uno Minda
Oil and Gas: Reliance Industries, Hindustan Petroleum Corporation
Telecom: Bharti Airtel
Power: Tata Power, JSW Energy
Internet: Info Edge
Real Estate: Oberoi Realty
 Cautious Stance
Getty Images
6/7
Cautious Stance
Infrastructure: Larsen & Toubro
Cement: UltraTech Cement
Capital Goods/Defense: CG Power and Industrial Solutions, GE Vernova T&D India and Hindustan Aeronautics Limited (HAL)
IT Services: Infosys
Tactically cautious/selective stance
ANI
7/7
Tactically cautious/selective stance
Pharmaceuticals: Lupin, Zydus Lifesciences, Dr. Reddy’s Laboratories
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Success
This article has been saved